Telemedicine in Japan: economic evaluations

Added May 15, 2020

Citation: Akiyama M, Yoo BK. A systematic review of the economic evaluation of telemedicine in Japan. Journal of Preventive Medicine and Public Health. 2016 Jul;49(4):183.

What is this? The COVID-19 pandemic is placing a strain on healthcare systems. Existing research on the use of telemedicine may provide useful information for policy makers.

In this systematic review, the authors searched for economic evaluations of telemedicine programs that had been implemented in Japan. They restricted their searches to articles published in English or Japanese and did the search in December 2014. They included 17 economic evaluations, 6 on settings connecting physicians for specialist consultations, and eleven on settings connecting healthcare providers and patients at home.

What works: The use of telemedicine in Japan improved economic efficiency.

What doesn’t work: Nothing noted.

What’s uncertain: The robustness of the reported benefit-to-cost ratio magnitude is uncertain because of the absence of sensitivity analyses.

The impact of public subsidy regulations on the benefit-to-cost ratio is uncertain.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.